How to Help Your Patients Save Money on Dilantin: A Provider's Guide to Savings Programs

Medication cost is one of the most common reasons patients with epilepsy discontinue or ration their anti-seizure medications — a potentially catastrophic outcome with phenytoin given its narrow therapeutic index. As a prescriber, being familiar with the cost landscape and available savings resources empowers you to address financial barriers proactively. This guide covers everything you need to help your patients access Dilantin or phenytoin at the lowest possible cost.

The Cost Landscape for Phenytoin in 2026

Understanding the full pricing picture helps you counsel patients effectively:

Brand Dilantin (100 mg, 90 capsules/30-day supply): Average retail price approximately $200–$210. With GoodRx coupon: as low as $63. With the Viatris savings card: up to $20 off per fill.

Generic phenytoin (100 mg, 90 capsules): Average retail approximately $46. With GoodRx or SingleCare: as low as $13–$20. With insurance (Tier 1): typically $0–$10 copay.

For most patients with insurance, generic phenytoin is essentially a minimal-cost drug. The most financially vulnerable patients are those who are uninsured or on fixed incomes without Part D coverage. Cost becomes more concerning for patients maintained on brand Dilantin for therapeutic consistency reasons.

The Viatris Dilantin Savings Card: Details for Providers

The Viatris savings card for brand Dilantin is available for eligible commercially insured patients:

Savings amount: Up to $20 per 30-day supply, maximum $240 per calendar year

Eligibility: US residents age 18+; must have commercial insurance coverage for Dilantin; not valid for Medicare, Medicaid, TRICARE, or other government payers

How to enroll: Patients register at dilantin.com/en/Savings or call 1-866-590-9400

Cash option program: For cash-pay patients without insurance, the Dilantin Cash Option Program can be accessed at 1-833-944-5687

When Should You Prescribe Generic vs. Brand Phenytoin?

This is a frequently debated clinical question given phenytoin's NTI status. Evidence-based considerations:

FDA-approved generic phenytoin products are required to demonstrate bioequivalence within 80–125% of the brand reference. For most stable patients, this is clinically acceptable.

The Epilepsy Foundation and many neurologists recommend that NTI anti-seizure medications (phenytoin, carbamazepine, valproate) not be switched between brand and generic — or between generic manufacturers — without prescriber-supervised monitoring.

If a patient is stable on generic phenytoin, there is generally no reason to switch to brand. If a patient is stable on brand Dilantin, switching to generic should involve level monitoring at 1–2 weeks and 4 weeks.

If cost is driving a patient toward brand-to-generic switching, help them access the GoodRx coupon for brand Dilantin first ($63) — which may be comparable to their generic copay, allowing therapeutic consistency.

Patient Assistance Programs for Uninsured or Underinsured Patients

For patients without insurance or with inadequate coverage, these resources can help:

Viatris Patient Assistance Program: For low-income uninsured patients. Contact 1-833-944-5687 for eligibility requirements.

NeedyMeds.org: Searchable database of patient assistance programs; patients and staff can search by drug name

RxAssist.org: Another PAP aggregator with program details and application forms

340B Covered Entity Pharmacies: If your practice or affiliated hospital qualifies as a 340B covered entity, patients may be able to access phenytoin at significantly reduced cost through your in-house or affiliated 340B pharmacy

Medicare Patients on Phenytoin: Key Coverage Points

For your Medicare patients:

Generic phenytoin is on the Part D formulary of virtually all Medicare plans — typically Tier 1 with a minimal or $0 copay after deductible

The Medicare Part D out-of-pocket cap is $2,000 in 2025 — meaning even patients on multiple drugs will not pay more than $2,000/year total for all covered Part D drugs

Medicare Low Income Subsidy (Extra Help) is available for patients with limited income and resources — this program pays Part D premiums, deductibles, and most copays. Eligible patients pay $0–$4 for generic drugs. Direct patients to ssa.gov/extrahelp to apply.

Prescribing Tips That Help Reduce Patient Costs

Prescribe 90-day supplies: Reduces pharmacy dispensing fees and often results in a lower per-day cost than 30-day fills

Write prescriptions for the maximum days' supply your state allows for mail order (typically 90 days)

Tell patients to compare their insurance copay against GoodRx/SingleCare prices at each fill — discount coupon prices often beat copays for generic drugs

If a patient needs brand for therapeutic consistency: write DAW and direct them to the Viatris savings card. With GoodRx, brand Dilantin is $63 — comparable to what many patients would pay for generic under insurance.

Helping Patients Find the Medication in Stock

Cost savings mean nothing if patients can't find their medication in stock. medfinder for providers is a resource you can recommend to patients or use in-clinic — it calls pharmacies in the patient's area and texts them a list of which pharmacies can fill their specific prescription. This reduces missed doses and the patient burden of calling around during shortage events.

You can also share the patient-facing companion to this guide: How to Save Money on Dilantin in 2026 — which walks patients through GoodRx, savings cards, and assistance programs step by step.